ロード中...
Guselkumab for the treatment of psoriasis – evidence to date
Psoriasis is a chronic, immune-mediated, inflammatory, and debilitating skin disease with significant impact on patients’ quality of life. Its pathogenesis is complex and not yet fully understood. However, the IL-23/IL-17 axis is currently considered the main pathogenic pathway in psoriasis. Guselku...
保存先:
| 出版年: | Drugs Context |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioExcel Publishing Ltd
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668503/ https://ncbi.nlm.nih.gov/pubmed/31391856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212594 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|